“…In the diseased myocardium, CaMKII plays central roles in processes such as maladaptive remodeling [1, 3, 44, 45, 48, 50, 72, 115, 117], arrhythmogenesis [63], interstitial fibrosis [3, 45] and apoptosis [21, 22, 103, 112]. As such, CaMKII is a promising target for pharmacological inhibition and the development of inhibitory compounds is racing ahead [73].…”